Low RKIP expression associates with poor prognosis in bladder cancer patients

Urothelial bladder cancer (UBC) is a heterogeneous type of disease. It is urgent to screen biomarkers of tumour aggressiveness in order to clarify the clinical behaviour and to personalize therapy in UBC patients. Raf kinase inhibitory protein (RKIP) is a metastasis suppressor, and its downregulatio...

ver descrição completa

Detalhes bibliográficos
Autor principal: Afonso, Julieta Alexandra Pereira (author)
Outros Autores: Longatto Filho, Adhemar (author), Martinho, Olga (author), Lobo, Francisco (author), Amaro, Teresina (author), Reis, R. M. (author), Santos, Lúcio L. (author)
Formato: article
Idioma:eng
Publicado em: 2013
Assuntos:
Bladder cancer
Biomarkers
RKIP
Lymphovascular invasion
Prognosis
Science & Technology
Texto completo:http://hdl.handle.net/1822/33584
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/33584

Texto Completo

http://hdl.handle.net/1822/33584

Registos relacionados